• 中文版
  • Home
  • About Us
    • Contract Research Organization
    • Contract Development and Manufacturing Organization
    • Accolades
    • Publications
  • Services Overview
  • Discovery Chemistry
    • Synthetic Chemistry
    • Medicinal Chemistry
    • Library Chemistry
    • Peptide Chemistry
    • Fragment Based Screening
    • Computer Aided Drug Design
    • Analytical Services
    • Protein Structure
  • Biology & Pharmacology
    • Oncology
    • Pathology Core Facility
    • Immunology
    • Tumor Immunology
    • Neuroscience
    • Cell Biology
    • In Vitro Biology
      • Kinases
      • Epigenetics
      • GPCR, NR, Ion-channel, Transporter
      • Ubiquitin & PROTAC
      • KRAS
      • COVID-19
      • Radiometric
      • Customized assay development
      • High throughput screening
      • MOA Study
    • Metabolic & Cardiovascular Diseases
  • DMPK / Exploratory Toxicology
    • DMPK / Exploratory Toxicology
    • Biomarkers, Preclinical & Clinical Sample Bioanalysis
    • Large molecule PK/BA services
  • Biologics Discovery
    • Antibody Discovery
    • Protein Science
    • Biologics Analytical Services
    • B Cell Cloning
  • Biologics CMC
    • Stable Cell Line Development
    • Process Development
    • Formulation Development
    • Aseptic Filling and Freeze-drying
    • Drug Developability / Manufacturability study
    • Final Container Extractables & Leachables Study
    • Analytical Development and Testing
    • GMP Production
  • Small Molecule CMC
    • Process R&D Services
    • Process Safety
    • Analytical Development
    • Pre-Formulation Development
    • Formulation Development
    • ICH Stability Studies
    • CMC CTD Support
    • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Call us today! +86 21 5132 0088

contact@chempartner.com
中文版
Shanghai ChemPartner Shanghai ChemPartner Shanghai ChemPartnerShanghai ChemPartner
  • Home
  • About Us
    • About ChemPartner
    • CRO
    • CDMO
    • Accolades
    • Publications
  • Services
    • Discovery Chemistry
      • Synthetic Chemistry
      • Medicinal Chemistry
      • Library Chemistry
      • Peptide Chemistry
      • Fragment Based Screening
      • Computer Aided Drug Design
      • Analytical Services
      • Protein Structure
    • Biology & Pharmacology
      • Oncology
      • Pathology Core Facility
      • Immunology
      • Tumor Immunology
      • Cell Biology
      • In Vitro Biology
      • Neuroscience
      • Metabolic & Cardiovascular Diseases
      • Epigenetics
    • DMPK / Exploratory Toxicology
      • DMPK / Exploratory Toxicology
      • Biomarkers, Preclinical & Clinical Sample Bioanalysis
      • Large molecule PK/BA services
    • Biologics Discovery
      • Antibody Discovery
      • Protein Science
      • Biologics Analytical Services
      • B Cell Cloning
    • Biologics CMC
      • Stable Cell Line Development
      • Process Development
      • Formulation Development
      • Aseptic Filling and Freeze-drying
      • Drug Developability / Manufacturability study
      • Final Container Extractables & Leachables Study
      • Analytical Development and Testing
      • GMP Production
    • Small Molecule CMC
      • Process R&D Services
      • Process Safety
      • Analytical Development
      • Pre-Formulation Development
      • Formulation Development
      • ICH Stability Studies
      • CMC CTD Support
      • Manufacturing
  • Blog
  • Careers
  • News & Events
    • Webinars
  • Contact Us
  • Download Center

Archive


Posts tagged "ChemPartner"

Home Tag ChemPartner
1ChemPartner will be at the Boulder Peptide Symposium 2018

ChemPartner will be at the Boulder Peptide Symposium 2018

Sep 25, 2018

ChemPartner, a leader in Peptide Synthesis and Development, will be at the Boulder Peptide Symposium, Sept. 24-27, 2018 in Boulder, Colorado. The program was organized by Dr. Yvonne Angell, who is the Head of Peptide Operations at ChemPartner. There are 43 speakers, including a Showcase of emerging Peptide Companies, a CEO roundtable, a Peptide Analytics […]

2Shanghai  ChemPartner  Announces Merger Deal Closure with Quantum

Shanghai ChemPartner Announces Merger Deal Closure with Quantum

Aug 16, 2018

SHANGHAI, Aug. 16, 2018 /PRNewswire/ — Shanghai  ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and development  services, announced the closure of the merger deal with Quantum Hi-Tech China Biological. Quantum, in a press release in 2017, announced their intent to join with Shanghai ChemPartner, a science-drive, technology-based Contract Research and Contract Manufacturing Organization (CRO/CMO) serving […]

3

Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery

Jun 28, 2018

EMERYVILLE, Calif., June 27, 2018 /PRNewswire/ — Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that it has entered into a collaboration with ChemPartner Co., Ltd. (ChemPartner) focused on accelerating ChemPartner’s monoclonal antibody (mAb) discovery workflow utilizing the Beacon® Optofluidic platform. The goal is to expand ChemPartner’s antibody discovery service offerings. Through the collaboration the companies […]

4

Dr. Ming Liu joins ChemPartner as Vice President and Head of Biology and Pharmacology

Jun 12, 2018

Shanghai, China (June 12, 2018) – Shanghai ChemPartner today announced the appointment of Ming Liu, Ph.D. as Vice President and the Head of Biology and Pharmacology at the company headquarters in Shanghai, China. Dr. Liu has more than 25 years of experience in drug discovery and development, with a  focus  on  pre-clinical evaluations of novel […]

5

Shanghai ChemPartner Sponsors Peptide Therapeutic Foundation(PTF)

Oct 25, 2017

Shanghai, China (October 25, 2017) – Shanghai ChemPartner today announced their sponsorship of the Peptide Therapeutics Foundation (PTF), a not-for-profit organization established to promote the research and development of peptide therapeutics. ChemPartner, a leading research organization, is a true partner in therapeutic peptide drug discovery and offers high-quality and cost-effective integrated partnerships for the biopharmaceutical […]

6ChemPartner Receives 2017 Best Life Science CRO Award from GHP

ChemPartner Receives 2017 Best Life Science CRO Award from GHP

Oct 22, 2017

ChemPartner was named Best Life Science CRO in the 2017 Global Health & Pharma (GHP) Magazine Healthcare & Pharmaceutical Awards. This award is part of the 2017 Healthcare & Pharmaceutical Awards, which recognizes the best-in-class organizations, departments and individuals of the year in healthcare and pharmaceutical industry. GHP has a readership of over 250,000 people, and […]

7

Dr. Lilly Xu joins ChemPartner as Vice President and Head of DMPK and Exploratory Toxicology

Jun 28, 2017

Shanghai, China (June 28, 2017) – Shanghai ChemPartner today announced the appointment of Lilly Xu, Ph.D. as Vice President and the Head of DMPK and Exploratory Toxicology at the company headquarters in Shanghai, China. Dr. Xu has more than 20 years of experience in the area of drug metabolism, pharmacokinetics and toxicology. She was one […]

8

ShangPharma Announces Second Milestone in Move to Enter Chinese Capital Market.

Jun 19, 2017

Shanghai, China (June 19, 2017) – ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced today the intent to join with Quantum Hi-Tech China Biological Co. Ltd. Quantum, in a press release earlier this week, announced their intent […]

9

ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner

Mar 24, 2017

Shanghai, China (March 24, 2017) – ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced today the intent for a strategic corporate restructuring. ShangPharma will be consolidating the Contract Research Organizations (CRO) and Contract Manufacturing Organizations (CMO) under […]

10ChemPartner at the 18th Shanghai International Froum on Biotechnology & Pharmaceutical Industry

ChemPartner at the 18th Shanghai International Froum on Biotechnology & Pharmaceutical Industry

Jun 22, 2016

The 18th International Forum on Biotechnology & Pharmaceutical Industry (Bio-Forum) was successfully held in Shanghai International Convention Center on June 20th-22nd, 2016.  Key themes of this conference revolves around the new technology and new development in the areas of novel drug development, clinical researches, biotechnology and pharmaceutical industry, as well as international technology transfer, transformation […]

  • 1
  • 2

Latest News

ChemPartner Makes Additional Investments in Biologics from Research to Manufacturing Capabilities

06/11/2020

Shanghai, China (June 9, 2020) – Shanghai ChemPartner...

ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research

05/12/2020

Shanghai, China (May 12, 2020) – Shanghai ChemPartner...

ChemPartner and the Gladstone Institutes Announce COVID-19 Research Collaboration

04/17/2020

SAN FRANCISCO, Calif. and SHANGHAI, China. (April 15, 2020)...

ChemPartner Introduces New State-of-the-Art Global Operation Center in Shanghai

04/02/2020

Shanghai, China (March 17, 2020) – Shanghai ChemPartner...

Dr. Jie Jack Li joins Shanghai ChemPartner as a Vice President of Discovery Chemistry

12/18/2019

Shanghai, China (December 17, 2019) – Shanghai ChemPartner...

Shanghai ChemPartner was awarded “TOP 10 CMOs in 2019”

Shanghai ChemPartner was awarded “TOP 10 CMOs in 2019”

07/19/2019

Contract manufacturers play a significant role when it comes...

Tag Cloud

2017 AACR Agreement Antibody Engineering art Berkeley Lights Best Life Science BIOtech Blend Boston Capital Market Chemistry ChemPartner Congratulates CPhI CPSA Shanghai 2016 CRO DMPK Exploratory Toxicology Labs layout Merger Deal PEGS PEGS CHINA Peptide Pharma Pharmacology product PTF Qidong Quantum Hi-Tech China Biological Research Facility San Diego San Francisco Shanghai Shanghai ChemPartner ShangPharma Sponsor Strategic Corporate Restructuring Tarveda Therapeutic Top 10 CMOs Vice President World ADC

Give us a Message

You can leave us a message by quick contact box and we'll get back to you, asap. Thanks!

Send Message

Logo

ChemPartner is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry.

Get started today.

Contact Us
  • Shanghai ChemPartner Co., Ltd.
  • 1F & 3F, Block A, 2829 JinKe Road, Zhangjiang Hi-Tech Park, PuDong New Area, Shanghai China, 201203
  • +86 21 5132 0088
  • contact@chempartner.com

© 2021 — Shanghai ChemPartner Co., Ltd. All Rights Reserved  About Us  Careers  Contact Us  Privacy Policy  Sitemap

  • Home
  • Contact
  • Buy Highend